Manulife (Manufacturers Life Insurance)’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,098
Closed -$81.8K 2828
2025
Q4
$81.8K Sell
10,098
-746
-7% -$8.15K ﹤0.01% 2746
2025
Q3
$154K Sell
10,844
-852
-7% -$11.3K ﹤0.01% 2667
2025
Q2
$153K Buy
11,696
+58
+0.5% +$797 ﹤0.01% 2649
2025
Q1
$173K Sell
11,638
-665
-5% -$11.4K ﹤0.01% 2534
2024
Q4
$223K Sell
12,303
-416
-3% -$5.6K ﹤0.01% 2575
2024
Q3
$171K Sell
12,719
-301
-2% -$4.44K ﹤0.01% 2722
2024
Q2
$180K Buy
13,020
+214
+2% +$3.39K ﹤0.01% 2642
2024
Q1
$240K Sell
12,806
-581
-4% -$11.6K ﹤0.01% 2508
2023
Q4
$303K Hold
13,387
﹤0.01% 2407
2023
Q3
$332K Hold
13,387
﹤0.01% 2321
2023
Q2
$376K Sell
13,387
-597
-4% -$14.8K ﹤0.01% 2213
2023
Q1
$312K Hold
13,984
﹤0.01% 2280
2022
Q4
$372K Sell
13,984
-406
-3% -$13.3K ﹤0.01% 2171
2022
Q3
$408K Sell
14,390
-310
-2% -$7.97K ﹤0.01% 2109
2022
Q2
$306K Sell
14,700
-6
-0% -$112 ﹤0.01% 2380
2022
Q1
$319K Sell
14,706
-4,214
-22% -$91.4K ﹤0.01% 2472
2021
Q4
$525 Sell
18,920
-876
-4% -$21.2K ﹤0.01% 2226
2021
Q3
$420K Sell
19,796
-2,125
-10% -$39.9K ﹤0.01% 2421
2021
Q2
$362K Buy
21,921
+454
+2% +$6.93K ﹤0.01% 2666
2021
Q1
$268K Sell
21,467
-1,767
-8% -$18.7K ﹤0.01% 2682
2020
Q4
$206K Sell
23,234
-410
-2% -$3.33K ﹤0.01% 2757
2020
Q3
$153K Hold
23,644
﹤0.01% 2668
2020
Q2
$146K Buy
23,644
+126
+0.5% +$773 ﹤0.01% 2622
2020
Q1
$159K Buy
23,518
+1,220
+5% +$11.6K ﹤0.01% 2418
2019
Q4
$259K Sell
22,298
-1,112
-5% -$12.6K ﹤0.01% 2423
2019
Q3
$242K Sell
23,410
-1,186
-5% -$11.7K ﹤0.01% 2451
2019
Q2
$231K Sell
24,596
-244
-1% -$1.88K ﹤0.01% 2541
2019
Q1
$175K Buy
24,840
+1,199
+5% +$10.3K ﹤0.01% 2475
2018
Q4
$174K Sell
23,641
-1,694
-7% -$14.2K ﹤0.01% 2357
2018
Q3
$221K Sell
25,335
-2,781
-10% -$28.4K ﹤0.01% 2707
2018
Q2
$317K Buy
28,116
+234
+0.8% +$2.79K ﹤0.01% 2736
2018
Q1
$309K Buy
27,882
+70
+0.3% +$877 ﹤0.01% 2702
2017
Q4
$355K Sell
27,812
-211
-0.8% -$2.79K ﹤0.01% 2562
2017
Q3
$399K Sell
28,023
-749
-3% -$9.38K ﹤0.01% 2439
2017
Q2
$372K Buy
28,772
+3,371
+13% +$43.4K ﹤0.01% 2516
2017
Q1
$365K Buy
25,401
+2,956
+13% +$43.5K ﹤0.01% 2404
2016
Q4
$350K Sell
22,445
-191
-0.8% -$2.62K ﹤0.01% 2361
2016
Q3
$267K Sell
22,636
-308
-1% -$4.06K ﹤0.01% 2555
2016
Q2
$319K Buy
22,944
+1,215
+6% +$16.1K ﹤0.01% 2336
2016
Q1
$255K Sell
21,729
-459
-2% -$5.83K ﹤0.01% 2426
2015
Q4
$364 Hold
22,188
﹤0.01% 2231
2015
Q3
$302 Hold
22,188
﹤0.01% 2334
2015
Q2
$281 Buy
22,188
+1,061
+5% +$12K ﹤0.01% 2566
2015
Q1
$250 Buy
21,127
+597
+3% +$6.84K ﹤0.01% 2565
2014
Q4
$257 Sell
20,530
-608
-3% -$6.21K ﹤0.01% 2467
2014
Q3
$196 Sell
21,138
-765
-3% -$5.87K ﹤0.01% 2648
2014
Q2
$142K Sell
21,903
-1,162
-5% -$7.68K ﹤0.01% 2977
2014
Q1
$186 Sell
23,065
-1,008
-4% -$9.92K ﹤0.01% 2776
2013
Q4
$240 Buy
24,073
+9,856
+69% +$68.4K ﹤0.01% 2577
2013
Q3
$86 Buy
14,217
+1,179
+9% +$6.75K ﹤0.01% 3067
2013
Q2
$67K Buy
+13,038
New +$66.8K ﹤0.01% 3053

Other funds holding CCRN

Manulife (Manufacturers Life Insurance)'s CCRN Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) sold out of Cross Country Healthcare (CCRN) in Q1 2026, closing a stake of 10,098 shares — an estimated $81.8K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CCRN in Q2 2013 and held it in 51 quarters. The position peaked at $420K in Q3 2021. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) reported no remaining Cross Country Healthcare position as of Q1 2026 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 10,098 Cross Country Healthcare shares in Q1 2026, an estimated $81.8K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Cross Country Healthcare in Q2 2013 and held it in 51 quarters.
  • Manulife (Manufacturers Life Insurance)'s Cross Country Healthcare position peaked at $420K in Q3 2021.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.